Approach and Pipeline

Targeted radiotherapy (TRT) is a medical method that uses targeted molecules to deliver radionuclides to tumor cells and tissues to accurately kill cancer cells at close range, thus achieving the purpose of treatment. TRT drug molecules generally contain three parts. The molecular binder, which is responsible for accurately identifying and binding tumor targets, the linker, which connects the molecule binder and the chelator, and improves the pharmaceutical application of the overall drug molecule, and the chelator, to form the firm complexation of radionuclides (for example: β-emitter 177Lu or α-emitter 225Ac).